Bayland Capital

Bayland Capital is a venture capital firm backing later-stage biotechnology, life sciences, oncology and pharmaceutical companies in China and the United States. The firm has acted as a lead or co-lead investor in Series B financings, making it most relevant for drug-development and therapeutics startups raising later-stage venture rounds.